Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.

Bayram Catak F., Catak M. C., Babayeva R., Toubia J., Warnock N. I., Celmeli F., ...More

The Journal of allergy and clinical immunology, vol.155, no.3, pp.784-791, 2025 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 155 Issue: 3
• Publication Date: 2025
• Doi Number: 10.1016/j.jaci.2024.11.032
• Journal Name: The Journal of allergy and clinical immunology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, CAB Abstracts, Food Science & Technology Abstracts, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database, Nature Index
• Page Numbers: pp.784-791
• Keywords: immune dysregulation, immunologic assessment, ruxolitinib, STAT3 GOF, transcriptomic profiling
• Hacettepe University Affiliated: Yes